A Guillen
Molecular pathology in the cancer clinic – where are we now and where are we headed?
Guillen, A; Smallwood, K; Killick, D R
Authors
K Smallwood
D R Killick
Abstract
Molecular pathology is a developing sub-microscopic discipline of pathology that studies the effects of molecular variations and mutations on disease processes. The ultimate goal of molecular pathology in cancer is to predict risk, facilitate diagnosis and improve prognostication based on a complete understanding of the biological impact of specific molecular variations, mutations and dysregulations. This knowledge will provide the basis for customised cancer treatment, so-called precision medicine. Rapid developments in genomics have placed this field at the forefront of clinical molecular pathology and there are already a number of well-established genetic tests available for clinical use including PCR of antigen receptor rearrangement and KIT mutational analysis. Moving beyond tests assessing a single gene, there are significant research efforts utilising genomics to predict cancer risk, forecast aggressive behaviour and identify druggable mutations and therapeutic biomarkers. Researchers are also investigating the use of circulating cells and nucleic acid for clinically useful low morbidity genomic assessments. If we are to realise the full potential of molecular pathology and precision medicine there are a number of challenges to overcome. These include developing our understanding of the underlying biology (in particular intra-tumoural heterogeneity), methodological standardisation of assays, provision of adequate infrastructure and production of novel therapeutics backed by high-quality clinical data supporting the precision medicine approach. The era of molecular pathology holds the potential to revolutionise veterinary cancer care, but its impact on clinical practice will depend upon the extent to which the inherent challenges can be overcome.
Citation
Guillen, A., Smallwood, K., & Killick, D. R. (2021). Molecular pathology in the cancer clinic – where are we now and where are we headed?. Journal of Small Animal Practice, 62(7), 507-520. https://doi.org/10.1111/jsap.13330
Journal Article Type | Article |
---|---|
Acceptance Date | Mar 4, 2021 |
Online Publication Date | May 11, 2021 |
Publication Date | 2021-07 |
Deposit Date | May 15, 2024 |
Publicly Available Date | May 15, 2024 |
Journal | Journal of Small Animal Practice |
Print ISSN | 0022-4510 |
Electronic ISSN | 1748-5827 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 62 |
Issue | 7 |
Pages | 507-520 |
DOI | https://doi.org/10.1111/jsap.13330 |
Keywords | Small Animals |
Additional Information | Received: 2019-08-08; Accepted: 2021-03-04; Published: 2021-05-11 |
Files
J Of Small Animal Practice - 2021 - Guillen - Molecular Pathology In The Cancer Clinic Where Are We Now And Where Are We
(2.4 Mb)
PDF
Licence
http://creativecommons.org/licenses/by/4.0/
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Version
VoR
You might also like
Mastocytosis in the skin in dogs: A multicentric case series
(2024)
Journal Article
Prognostic factors and outcome in cats with thymic epithelial tumours: 64 cases (1999‐2021)
(2023)
Journal Article
Leukemia cutis as a prominent clinical sign in a dog with acute myeloid leukemia
(2024)
Journal Article
Downloadable Citations
About RVC Repository
Administrator e-mail: publicationsrepos@rvc.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search